Drugs / iMSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06321198 | Feb 2024 → Mar 2027 expected | acute graft versus host disease | Anhui Provincial Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iMSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06321198 ↗ |
| Modality | Cell therapy | “Human Induced Pluripotent Stem Cell Derived Mesenchymal Stromal Cells” NCT06321198 ↗ |
| Route | Other | “iMSC injection” NCT06321198 ↗ |